<DOC>
	<DOCNO>NCT01687101</DOCNO>
	<brief_summary>This open label pilot study 25 subject diagnosis episodic migraine without aura . STOPAIN over-the-counter product use temporary relief minor ache pain muscle joint associated simple backache , arthritis , strain , bruise sprain . We plan subject apply product single migraine attack see alleviate headache pain associate symptom .</brief_summary>
	<brief_title>STOPAIN Treatment Single Migraine Attack</brief_title>
	<detailed_description>This open label , 2 visit , pilot study 25 subject diagnosis episodic migraine without aura accord International Classification Headache Disorders ( 2nd Edition-2004 ) . Subjects screen Visit 1 properly consent participation study . Screening procedure include assessment medical history , headache history , current medication , vital sign , height weight measurement urine pregnancy test woman childbearing potential . Investigators determine eligibility study subject . Subjects instruct apply topical gel treat migraine attack . In addition , subject instruct complete take home diary . The study medication use home treat single migraine attack . At time at-home treatment subject apply study medication . The gel apply area abut back base skull base neck span behind ear . The quantity shall two pump meter dose bottle . The best way apply pump onto fingertip apply gel one-half application area pump onto fingertip apply gel half application area . Massage 5 10 second make sure reasonably uniform coverage . ( Do cover cloth bandage lie pillow gel completely dry - 10 minute . ) Do get gel eye onto mucus membrane . The gel toxic cause burn sensation eye mucus membrane . Wash hand soap warm water application . The gel give rise cool sensation may feel like mild moderate sting burn sensation . That normal . Anything mild moderate sting burn sensation expect noted diary . If reduction symptom 30 minute repeat application . If relief 2 hour subject may use rescue medication . Completed subject diary provide data headache severity presence absence nausea , vomit , photophobia phonophobia . Time resolution headache accompany symptom collect . The subject record migraine pain severity presence absence associate symptom 30 , 60 , 90 minute 2 , 4 , 24 hour administration study drug . Subjects ask treat single migraine attack within 8 week Visit 1 . After treat attack complete diary , ask return Jefferson Headache Center final visit ( Visit 2 ) return diary study supply mail . Shipping material provide participant .</detailed_description>
	<mesh_term>Headache</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Menthol</mesh_term>
	<criteria>Male female subject age 18 65 , inclusive Subjects diagnose episodic migraine , without aura accord IHS criterion least one year prior screening Subjects experience 1 10 migraine attack ( inclusive ) per month ( previous 6 month ) 15 day headache per month . Subject use agrees use duration participation medically acceptable form contraception ( determined investigator ) , female childbearing potential Subjects able understand comply study procedure . Subject provide write informed consent prior screen procedure conduct Pregnant and/or lactate woman Subjects , investigator 's opinion , history evidence medical psychiatric condition would expose increase risk significant adverse event would interfere assessment efficacy tolerability trial Subjects participate investigational drug trial 30 day prior screen visit Subjects currently history basilar hemiplegic migraine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>acute migraine</keyword>
	<keyword>acute migraine treatment</keyword>
	<keyword>topical treatment</keyword>
</DOC>